ClinicalTrials.Veeva

Menu

Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer

P

Protgen

Status

Unknown

Conditions

Colorectal Cancer

Treatments

Device: Hsp90

Study type

Interventional

Funder types

Industry

Identifiers

NCT02324114
hsp90a2011-03

Details and patient eligibility

About

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients.

Full description

Detect plasma Hsp90α concentration of colorectal cancer patients, healthy volunteers, benign colorectal diseases patients, validate accuracy, specificity and sensitivity of Hsp90α kit.

Enrollment

1,100 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • colorectal cancer patients, healthy volunteers, benign colorectal diseases patients

Exclusion criteria

  • Patients who previously accepted radiotherapy

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,100 participants in 1 patient group

Rectal cancer
Experimental group
Description:
Detect plasma Hsp90α concentration of patients,
Treatment:
Device: Hsp90

Trial contacts and locations

1

Loading...

Central trial contact

Xianrang Song, MD; Lisheng Liu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems